“Chronic non-healing wounds among diabetics and the elderly are an increasing clinical problem,” says Professor Wendy L. Havran.
“We’ve gotten very good at targeting RNA with small molecules, something a lot of people said couldn’t be done,” says Associate Professor Matthew Disney.
The consortium, led by Professor and Chairman Emeritus Richard Ulevitch, is now especially interested in the intersection between innate and adaptive immunity.
Professor Paul D. Robbins and Associate Professor Laura J. Niedernhofer join Scripps Florida.